Stocklytics Platform
Asset logo for symbol ABEO
Abeona Therapeutics
ABEO72
$5.23arrow_drop_up2.55%$0.12
High Growth
Asset logo for symbol ABEO
ABEO72

$5.23

arrow_drop_up2.55%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Abeona Therapeutics (ABEO) Stocklytics Forecast

Abeona Therapeutics Inc (ABEO) is a biopharmaceutical company that focuses on developing gene and cell therapies for rare genetic diseases. The company's stock price has been a subject of interest for investors and analysts, with many trying to predict its future performance. While it is challenging to accurately forecast stock prices, there are various factors that can influence ABEO's stock price in the coming years.
One important aspect to consider is the progress of Abeona Therapeutics' pipeline. The company is currently developing several potential therapies for rare diseases like Sanfilippo syndrome, EB-101 for recessive dystrophic epidermolysis bullosa, and ABO-202 for CLN1 disease. Positive results from clinical trials and regulatory approvals can significantly impact the stock price in a positive way. Conversely, setbacks in clinical trials or regulatory challenges may negatively affect the stock.
add Abeona Therapeutics  to watchlist

Keep an eye on Abeona Therapeutics

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Abeona Therapeutics (ABEO) stock?

Analysts have set a target price of $18.73 for Abeona Therapeutics (ABEO), based on forecasts from 15 analysts. The predicted price range extends from a high of $40 to a low of $1. This represents a potential increase of up to 664.09% and a decrease of -80.9% from the current price of $5.24. These forecasts are as of 2017 Oct 12.
help

What are the analyst ratings for Abeona Therapeutics (ABEO) stock?

The analyst ratings for Abeona Therapeutics (ABEO) are distributed as follows: 5 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Abeona Therapeutics .
help

What is the AI price prediction for Abeona Therapeutics (ABEO) stock?

At present, there is no AI or machine-learning-based price prediction available for Abeona Therapeutics (ABEO) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level